journal article·2018-01-02Open access

Glutaraldehyde-polymerized hemoglobin and tempol (PolyHb-tempol) has superoxide dismutase activity that can attenuate oxidative stress on endothelial cells induced by superoxide anion

Mengdi Wu, Kun Feng, Qiuhui Li, Huiya Ma, Hongli Zhu, Yudou Xie, Gaofei Yan, Chao Chen, Kunping Yan

Abstract

A Tempol compound with an amine group (4-amino-2,2,6,6-tetramethylpiperidine-1-oxyl, NH2-Tempol) was cross-linked to hemoglobin in a one-step polymerization reaction to produce a novel hemoglobin-based oxygen carrier (HBOC) designated PolyHb-Tempol. The reaction parameters, including the reaction time, pH, temperature, and ratio of reactants, were optimized, and the physiochemical properties of the resulting product were characterized. PolyHb-Tempol didn't show any toxicity towards endothelial cells. Furthermore, from observations of cell morphology and viability, PolyHb-Tempol showed a significant ability to inhibit or eliminate oxidative stress induced by superoxide free radicals. These results suggest that PolyHb-Tempol may potentially be suitable as an HBOC.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Hemoglobin structure and function · Electron Spin Resonance Studies · Nitric Oxide and Endothelin Effects

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

College of Life Science, Northwest University, Xi’an, P.R. China;

National Engineering Research Center for Miniaturized Detection System, Xi’an, P.R. China;

Shaanxi Lifegen Co., Ltd., Xi’an, P.R. China

Funding

National Science and Technology Major · Natural Science Foundation · Science and Technology Department and “Special Research Foundation” · Education Department of Shaanxi Province · National Science and Technology Major Projects for Major New Drugs Innovation and Development · Shaanxi Science and Technology Department and Special Research Foundation · National Natural Science Foundation of China

References (35)

Show source-provided references
1. 10.1007/978-1-4939-3023-4_5610.1007/978-1-4939-3023-4_56 ↗
2. 10.1111/aor.1233110.1111/aor.12331 ↗
3. 10.1371/journal.pone.015390910.1371/journal.pone.0153909 ↗
4. 10.1042/BJ2006034110.1042/BJ20060341 ↗
5. BorettiFS BP · J Clin Invest · 2009 · 119 · 2271
6. 10.1089/ars.2009.279810.1089/ars.2009.2798 ↗
7. 10.1007/s11655-014-1980-610.1007/s11655-014-1980-6 ↗
8. 10.1371/journal.pone.016170610.1371/journal.pone.0161706 ↗
9. 10.1016/j.imbio.2015.09.00510.1016/j.imbio.2015.09.005 ↗
10. 10.1016/j.jacc.2014.06.37210.1016/j.jacc.2014.06.372 ↗
11. 10.1007/s10600-013-0574-410.1007/s10600-013-0574-4 ↗
12. 10.1016/j.freeradbiomed.2004.04.00810.1016/j.freeradbiomed.2004.04.008 ↗
13. 10.1016/j.brainres.2004.03.04810.1016/j.brainres.2004.03.048 ↗
14. 10.3109/21691401.2012.76265210.3109/21691401.2012.762652 ↗
15. 10.1021/cr000040l10.1021/cr000040l ↗
16. 10.1021/jm101232t10.1021/jm101232t ↗
17. 10.3109/21691401.2013.77557710.3109/21691401.2013.775577 ↗
18. 10.1016/j.metabol.2015.10.03010.1016/j.metabol.2015.10.030 ↗
19. 10.1021/bi101562m10.1021/bi101562m ↗
20. 10.5114/fn.2013.3419510.5114/fn.2013.34195 ↗
21. 10.1016/j.fct.2013.11.01810.1016/j.fct.2013.11.018 ↗
22. 10.1016/0014-5793(78)80514-610.1016/0014-5793(78)80514-6 ↗
23. Sellards AW · J Med Res · 1916 · 34 · 469
24. Bunn HF · Trans Assoc Am Physicians · 1968 · 81 · 147
25. 10.1111/j.1476-5381.2009.00259.x10.1111/j.1476-5381.2009.00259.x ↗
26. 10.1016/j.brainres.2009.09.06110.1016/j.brainres.2009.09.061 ↗
27. 10.1016/j.foodchem.2014.06.02110.1016/j.foodchem.2014.06.021 ↗
28. 10.1038/984910.1038/9849 ↗
29. 10.1038/nrd130710.1038/nrd1307 ↗
30. 10.1089/ars.2009.279910.1089/ars.2009.2799 ↗
31. 10.1016/j.tibtech.2014.02.00610.1016/j.tibtech.2014.02.006 ↗
32. 10.1097/ALN.0b013e3181cd783810.1097/ALN.0b013e3181cd7838 ↗
33. 10.1111/j.1525-1594.2004.07340.x10.1111/j.1525-1594.2004.07340.x ↗
34. 10.1016/j.reprotox.2015.01.00510.1016/j.reprotox.2015.01.005 ↗
35. 10.1016/j.bbapap.2009.04.00810.1016/j.bbapap.2009.04.008 ↗